Revenue Cycle

The 30-year veteran most recently served as the executive vice president and CFO of JDA Software Group, a privately-held supply chain provider of software and SaaS solutions.

Although many organizations claim interoperability is a major focus, progress is slow, at best. For HL7 CEO Charles Jaffe, the reason is a lack of financial reward, as for-profit vendors can’t be expected to “connect everyone on their own dime.”

Some would pay as much as $1,000 for genomic sequencing offered through employer health plans.

Goal is to boost early-stage healthcare technologies and startups that have a link to Houston and the medical center.

Change will now offer customers a hosted service that combines multiple credentialing documents into a single instance.

Emerging technologies will start to gain some firmer footing in the year ahead, moving out of pilot testing and into production environments.

As genomic tests and therapies advance, proliferate and get easier to administer, the group wants payers to be more transparent about how providers can bill for them.

While EHRs and data security get all the attention, there are more immediate opportunities for the digital ledger technology.  

And that frustration could mean they fall short of payment incentive goals, SA Ignite says.

Called MaaS, the new web-based electronic health record enables small hospitals to be up and running with the technology within six months, the company says.